A Covid-19 vaccine candidate being developed in China has been found to be safe and to trigger an antibody response, early results have shown. Researchers said those aged 60 and over were slower to respond to the BBIBP-CorV vaccine, but they said it was "encouraging" that the vaccine did trigger such a response. They also found antibody levels to be lower in those aged 60 to 80 years, compared with those aged 18 to 59.
Continue reading...
No comments:
Post a Comment